Institutional Ownership
Bristol-Myers Squibb Co
CUSIP 110122108COMBMYQ1 2026
Latest EPS (Diluted)
$1.62
Q2 2026 · Jun 30, 2026
Latest Revenue
$12.97B
Reported quarter
Latest Net Income
$3.32B
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Q2 2026 | $1.62 | $1.62 | $12.97B | $3.32B | 10-Q |
| Mar 31, 2026 | Q1 2026 | $1.31 | $1.31 | $11.49B | $2.68B | 10-Q |
| Sep 30, 2025 | Q3 2025 | $1.08 | $1.08 | $12.22B | $2.20B | 10-Q |
| Jun 30, 2025 | Q2 2025 | $0.64 | $0.64 | $12.27B | $1.31B | 10-Q |
| Mar 31, 2025 | Q1 2025 | $1.21 | $1.20 | $11.20B | $2.46B | 10-Q |
| Sep 30, 2024 | Q3 2024 | $0.60 | $0.60 | $11.89B | $1.21B | 10-Q |
| Jun 30, 2024 | Q2 2024 | $0.83 | $0.83 | $12.20B | $1.68B | 10-Q |
| Mar 31, 2024 | Q1 2024 | $-5.89 | $-5.89 | $11.87B | -$11.91B | 10-Q |
| Sep 30, 2023 | Q3 2023 | $0.94 | $0.93 | $10.97B | $1.93B | 10-Q |
| Jun 30, 2023 | Q2 2023 | $0.99 | $0.99 | $11.23B | $2.07B | 10-Q |
| Mar 31, 2023 | Q1 2023 | $1.08 | $1.07 | $11.34B | $2.26B | 10-Q |
| Sep 30, 2022 | Q3 2022 | $0.75 | $0.75 | $11.22B | $1.61B | 10-Q |